ERBA Diagnostics, Inc. (NYSE MKT:ERB), a fully integrated in vitro diagnostics company, reported its financial results for the three and nine months ended September 30, 2013. Sanjiv Suri, Interim Chief Executive Officer of ERBA Diagnostics, said, “I am pleased to report a continuation in the third quarter of 2013 of the turnaround we are experiencing, with a significant year-over-year improvement from net loss in the third quarter of 2012 to positive net income in the third quarter of 2013.
Help employers find you! Check out all the jobs and post your resume.
